您好!欢迎来到     ChemDig
发布供应信息 我的ChemDig 供应商中心 网站导航 中文图标 中文 图标
热搜 : 阿维菌素
首页 > 产品详情 > 研究领域 > 心血管系统 > 血液 > 血压调节
产品图片

包装 50mg | 1g | 5g | 25g | 100g
纯度 ≥98%
发货地 现货 品牌 阿拉丁
最小起订 1MG
立即询价
查看联系方式
实时库存

产品详情

中文名称 别名
CasNo 544-31-0 产品类别 研究领域,心血管系统,血液,血压调节

产品名称

英文名称:Palmitoylethanolamide

同义词

Palmitoylethanolamide、Palmidrol、544-31-0、N-(2-Hydroxyethyl)hexadecanamide、Impulsin、Palmitoyl ethanolamide、Palmitamide MEA、N-palmitoylethanolamine、N-(2-Hydroxyethyl)palmitamide、Loramine P 256、Hydroxyethylpalmitamide、Palmitic acid monoethanolamide、Palmitoyl、N-(2-羟乙基)十六酰胺、N-(2-羟乙基)十六烷、N-羟乙基棕榈酰胺、棕榈酰

产品性质

CAS编号:544-31-0

分子式:C18H37NO2

分子量:299.492

MDL号:MFCD00020562

PubChem编号:4671

别名:N-(2-羟乙基)十六酰胺|N-(2-羟乙基)十六烷|N-羟乙基棕榈酰胺|棕榈酰

英文别名:Palmitoylethanolamide|Palmidrol|544-31-0|N-(2-Hydroxyethyl)hexadecanamide|Impulsin|Palmitoyl ethanolamide|Palmitamide MEA|N-palmitoylethanolamine|N-(2-Hydroxyethyl)palmitamide|Loramine P 256|Hydroxyethylpalmitamide|Palmitic acid monoethanolamide|Palmitoyl

规格或纯度:≥98%

英文名称:Palmitoylethanolamide

生化机理:Endogenous CB2 cannabinoid receptor agonist.Endogenous lipid that acts as a potent, selective GPR55 agonist (EC 50 = 4 nM). Highly selective over CB 2 and CB 1 receptors (EC 50 values are 19.8 and >30 μM, respectively). Fatty acid amide hydrolase (FAAH) and PEA-preferring acid amidase (PAA) substra

储存温度:-20°C储存

运输条件:超低温冰袋运输

备注:10mg/50mg卖完停产,不再备货 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。

产品介绍:Palmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive, anti-inflammatory, anti-convulsant and immunosuppresant activity. Palmitoylethanolamide acts by binding to an unidentified cannabinoid receptor that is similar to CB2. It also acts as a selective activator of the GPR55 receptor. In addition, this compound directly activates PPARα, producing an anti-inflammatory response.An endogenous cannabinoid agonist, FAAH inhibitor, and PPARα agonistPalmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive, anti-inflammatory, anti-convulsant and immunosuppresant activity. Palmitoylethanolamide acts by binding to an unidentified cannabinoid receptor that is similar to CB2. It also acts as a selective activator of the GPR55 receptor. In addition, this compound directly activates PPARα, producing an anti-inflammatory response.An endogenous cannabinoid agonist, FAAH inhibitor, and PPARα agonist

IUPAC Name:N-(2-hydroxyethyl)hexadecanamide

INCHI:InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)

InChi Key:HXYVTAGFYLMHSO-UHFFFAOYSA-N

Canonical SMILES:CCCCCCCCCCCCCCCC(=O)NCCO

Isomeric SMILES:CCCCCCCCCCCCCCCC(=O)NCCO

WGK Germany:3

PubChem CID:4671

Wikipedia:N-palmitoylethanolamine

CAS Registry No.:544-31-0

ChEBI:CHEBI71464

ChEMBL Ligand:CHEMBL417675

DrugCentral Ligand:2045

GPCRdb Ligand:N-palmitoylethanolamine

溶解性:Soluble in DMSO (20 mM), ethanol (25 mM), chloroform, THF ( at 30 °C), and DMF (~10 mg/ml).

敏感性:对热敏感

熔点:99 °C

象形图:

信号词:Danger

危险声明:H315 Causes skin irritationH411 Toxic to aquatic life with long lasting effectsH318 Causes serious eye damage

预防措施声明:P273,P280,P302+P352,P321,P501,P264,P362+P364,P391,P264+P265,P305+P354+P338,P317,P332+P317

Merck Index:6995

个人防护装备:Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter

产品包装

纯度包装库存所在地
≥98%50mg现货
≥98%1g现货
≥98%5g现货
≥98%25g现货
≥98%100g现货
免责声明:以上所展示的信息由企业自行提供,内容的真实性 、准确性和合法性由发布企业负责,chemdig对此不承担任何保证责任。 同时我们郑重提醒各位买/卖家,
交易前 请详细核实对方身份,切勿随意打款或发货,谨防上当受骗。如发现虚假信息,请向chemdig举报。
上海阿拉丁生化科技股份有限公司
X

上海阿拉丁生化科技股份有限公司

邮箱 market@aladdin-e.com
联系人 18521732826

咨询请告知是在ChemDig上看到的,有助于交易达成。

联系电话:
Copyright © 京ICP备2023001500号